Follitropin alpha (r-FSH)
Pre-clinicalCompleted 0 watching 0 views this week💤 Quiet
23
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Ovulation Induction
Conditions
Ovulation Induction
Trial Timeline
Mar 1, 2004 → Jun 1, 2005
NCT ID
NCT01111084About Follitropin alpha (r-FSH)
Follitropin alpha (r-FSH) is a pre-clinical stage product being developed by Merck for Ovulation Induction. The current trial status is completed. This product is registered under clinical trial identifier NCT01111084. Target conditions include Ovulation Induction.
Hype Score Breakdown
Clinical
5
Activity
2
Company
10
Novelty
2
Community
1
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01111084 | Pre-clinical | Completed |
Competing Products
13 competing products in Ovulation Induction